IQVIA Holdings (IQV) showcases long-term growth, obtaining buy recommendations from Leerink Partners and Bank of America Securities. The company is set to release Q2 2025 earnings, following an outperformance in Q1 with higher-than-expected revenue and bottem line. IQVIA Holdings unveiled a significant AI collaboration with NVIDIA, underlining a strong commitment to technological advancements. Despite a lowered price target from Leerink Partners, the firm maintains its outperform rating. Billionaire Israel Englander sees IQVIA Holdings as a valuable pick with a significant upside. Conversely, doubts regarding shareholder exit and underperformance compared to Dow and Nasdaq persist. Still, IQVIA has witnessed a hike in the trading volume and enjoyed a robust 11% share price rise over the last week. Besides, it recently issued $2 billion in senior notes. The introduction of new AI agents for healthcare and life sciences has boosted its innovation standing. However, a lowered guidance and recent underperformance compared to its competitors imply a mixed future outlook.
